← Back to Patent Explorer
US4544552A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the preparation of cell and tissue regenerating substances

Assignee: ICN Switzerland AG
•
Filing: 1983-05-26
•
Granted: 1985-10-01
•
Expires: 2003-05-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Glycolipids having cell- and tissue-regenerating properties are isolated from the blood or organ homogenates of mammals by subjecting the starting material to autolysis and dialysis against an alcoholic-aqueous medium. The glycolipids can be isolated, and purified, from the resulting crude product by precipitation with ethanol or extraction followed by chromatography. The process gives relatively high yields of active compounds; it is outstandingly suitable for industrial application.

Inventors

  • 👤 Wolfgang Fraefel
  • 👤 Roland Tschannen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:07
CPC Classifications
A; A61; A61K; A61K31/00; A61K35/00; A61K35/12; A61K35/14

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 50 words
A process for the preparation of cell- and tissue-regenerating substances of the glycolipid series from blood or organ homogenates from mammals, comprising subjecting the blood or organ homogenate to autolysis and dialysis against an alcoholic-aqueous medium, the autolysis and dialysis being carried out simultaneously and continuously, in a countercurrent process.
Claim 2
Dependent Claim 50 words
A process for the preparation of cell- and tissue-regenerating substances of the glycolipid series from blood or organ homogenates from mammals, comprising subjecting the blood or organ homogenate to autolysis and dialysis against an alcoholic-aqueous medium, the autolysis and dialysis being carried out simultaneously and continuously, in a countercurrent process.
Claim 3
Dependent Claim 17 words
A process according to claim 1, wherein bovine or calf blood is used as the starting material.
Claim 4
Dependent Claim 43 words
A process according to claim 1, wherein the glycolipids are precipitated from the resulting dialysis by adding ethanol and leaving the ethanolic solution formed to stand at a temperature in the range from -15° to -25° C., and the glycolipids are separated off.
Claim 5
Dependent Claim 58 words
A process according to claim 1, wherein the resulting dialystate is separated into solid/liquid or liquid/liquid phases by addition of a solvent or solvent mixture which is water-immiscible or water-miscible only to a limited extent, the glycolipids passing into the solid phase or into the organic, less polar phase, and the phase containing the glycolipids is separated off.
Claim 6
Dependent Claim 40 words
A process according to claim 4, wherein said solvent or solvent mixture is selected from the group consisting of ethers, hydrocarbons, halogenated hydrocarbons, alcohols, carboxylic acid esters and mixtures thereof, which are water-immiscible or water-miscible only to a limited extent.
Claim 7
Dependent Claim 15 words
A process according to claim 1, wherein calf blood is used as the starting material.
Claim 8
Dependent Claim 21 words
A process according to claim 4, wherein said glycolipids pass into said organic phase, which is then dried under mild conditions.
Claim 9
Dependent Claim 11 words
A method according to claim 1, further comprising recovering the glycolipid.

References Cited (Backward Citations)

US3526697A Cited
US3672954A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-09-30 1989-04-01 1989-10-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-09-30 1993-04-01 1993-10-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-09-30 1997-04-01 1997-10-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag